Emis buoyed by Hunt NHS rhetoric as market share swells - UPDATE
12th Jul 2013 07:33
Clinical software supplier Emis has generated stronger revenue and visibility in the first half but profits have remained flat. The company has been encouraged by recent comments by Health Secretary Jeremy Hunt about "joined-up services" that bodes well for its offering, while the exit of a competi
Read moreTuesday broker round-up UPDATE
30th Apr 2013 08:20
Aberdeeen Asset Management: Morgan Stanley raises target price from 478p to 548p retaining an overweight rating. Bank of America ups target price from 455p to 475p and leaves its neutral rating unchanged. JP Morgan increases target price from 532p to 573p and maintains an overweight rating. Citigrou
Read moreThursday broker round-up UPDATE
14th Mar 2013 07:11
Amara Mining: After having been under review, Cantor Fitzgerald reinitiates coverage with a price target of 81p and a buy recommendation. Antofagasta: Citigroup shifts target price from 990p to 1000p, but retains its sell recommendation. Ashtead Group: Investec raises target price from 475p to 700
Read moreEmis Group's CEO steps down
4th Feb 2013 13:12
EMIS Group's Chief Executive Officer (CEO), Sean Riddell, is retiring from his full-time role to focus on family commitments. The supplier of clinical software and related services to GP practices and other healthcare practitioners said Chief Administrative Officer, Chris Spencer, will work as chie
Read more